Medical Journal August 2022 Digital Edition
Post Views: 1,575
BY Staci Saint-Preux, Industry Manager, StormGeo It has been a relatively quiet hurricane season – so far. Traditionally the peak of the Atlantic tropical season is September 10th, with two-thirds of activity occurring between August 20th and October 10th. As we move into this period, meteorologists at StormGeo are continuing to see signs of an active hurricane season along the Gulf Coast and Atlantic Seaboard. When hurricanes make landfall, emergency managers, facility directors,...
Houston Methodist Clear Lake Hospital is expanding its presence across the Bay Area by opening a second emergency care center early next year. The Houston Methodist Emergency Care Center (ECC) in League City will make it easier and more convenient for residents to receive high-quality, expert treatment from board-certified emergency care physicians. “Many people put off seeking critical medical care because they are worried about long waits in the emergency room,” said Levi...
BY Colleen Byrom and Beth Anne Jackson, Brown and Fortunato On June 24, 2022, the U.S. Supreme Court published its opinion in Dobbs v. Jackson Women’s Health Organization. Penned by Justice Alito, the Court held that the U.S. Constitution does not “confer a right to abortion” and that the people and their elected state officials retain the authority to regulate abortion, thus overturning the Court’s prior decisions in Roe v. Wade and Planned Parenthood...
BY Micah Dickie, Associate, and Patrick Dalin, Of Counsel, Fisher Phillips Federal workplace safety officials are placing Texas employers and healthcare organizations under increasing scrutiny – which means you need to develop a proactive plan to put yourself in the best position to respond. In a recent analysis, Bloomberg Law found that OSHA has already conducted more inspections of hospitals and nursing homes across the nation in 2022 than it did in all of...
BY Catherine Lightfoot, CPA, CHBC, Director of Healthcare, EEPB Why it might be worth owning rather than leasing in this economic climate Delivering care is the primary and extremely demanding business of any healthcare provider. So, why would you even consider owning your own real estate? Isn’t it just easier to lease? Well, like any debate, there are pros and cons to either side of the argument. This article attempts to answer the question of...
BY John Hawkins, President/CEO, Texas Hospital Association With no shortage of polarizing issues circulating in Texas right now, one thing is clear no matter your politics: Mental health is top of mind. The stress of an ongoing pandemic layered with racial tensions, school shootings, divisive abortion laws, and a turbulent economy have pushed behavioral health front and center. It’s an unfortunate circumstance, and it’s clear that almost everyone is hurting in some way....
BY Victor S. Sierpina, MD, WD and Laura Nell Nicholson Professor of Integrative Medicine, Professor of Family Medicine at UTMB-Health and the John Sealy School of Medicine In stillness, all things are healed. – Taoist proverb The most recent edition of Explore: Journal of Health and Healing, a leading publication in Integrative Medicine, published a systematic review and meta-analysis by Bahar Aras and co-authors that examined the effects of Tai Chi on functional...
Researchers from Rice University and the University of Texas MD Anderson Cancer Center have discovered potential new drugs that work in concert with other drugs to deliver a deadly one-two punch to leukemia. The potential drugs are still years away from being tested in cancer patients, but there are innovative methods that led to their discovery. In previous studies, the research groups of Rice biochemist Natasha Kirienko and MD Anderson physician-scientist Marina Konopleva screened some 45,000...
Renal cell carcinoma (RCC) tumors generally display specific genetic alterations that cause cancer cells to increase the metabolism of glutamine. Dual targeting of glucose and glutamine metabolism by the mTOR inhibitor everolimus, plus the glutaminase inhibitor telaglenastat, showed preclinical synergistic anticancer effects. The Phase II ENTRATA study, led by Nizar Tannir, M.D., enrolled 69 patients with a median of three prior lines of therapy for advanced metastatic disease, including 100% with two or more prior...